Renal research
Our researchers are working at the forefront of global trends in research to trial new clinical treatments and to understand the cellular and molecular basis of renal disease.
Australasian Kidney Trials Network
The Australasian Kidney Trials Network (AKTN) is located at the Princess Alexandra Hospital campus, Woolloongabba.
It is a not-for-profit research organisation that designs, conducts and supports investigator-initiated clinical trials with the aim of improving life for people with Chronic Kidney Disease (CKD). It consists of a group of Nephrologists and other doctors, nurses, researchers, dieticians, scientists and other health professionals who conduct clinical trials in kidney disease. Because of their interest in renal disease and kidney health, they want to find better treatments for people living with kidney disease. All AKTN clinical trials are designed with patients with kidney disease in mind. A patient with kidney disease sits on the Scientific Committee as a consumer representative to ensure AKTN trials consider quality of life, symptoms and treatments important to people with kidney disease.
To date, the AKTN have successfully completed eight trials with a record number expected for 2017. Our research helps bring evidence to medical practice and in doing so improve outcomes for CKD patients.
The Australasian Kidney Trials Network (AKTN) is located at the Princess Alexandra Hospital campus, Woolloongabba.
It is a not-for-profit research organisation that designs, conducts and supports investigator-initiated clinical trials with the aim of improving life for people with Chronic Kidney Disease (CKD). It consists of a group of Nephrologists and other doctors, nurses, researchers, dieticians, scientists and other health professionals who conduct clinical trials in kidney disease. Because of their interest in renal disease and kidney health, they want to find better treatments for people living with kidney disease. All AKTN clinical trials are designed with patients with kidney disease in mind. A patient with kidney disease sits on the Scientific Committee as a consumer representative to ensure AKTN trials consider quality of life, symptoms and treatments important to people with kidney disease.
To date, the AKTN have successfully completed eight trials with a record number expected for 2017. Our research helps bring evidence to medical practice and in doing so improve outcomes for CKD patients.
Centre for Kidney Disease Research
The CKDR is one of Australia's leading kidney disease research centres with an international reputation for excellence in research. The researchers of the CKDR are working at the forefront of global trends in research to trial new clinical treatments and to understand the cellular and molecular basis of kidney disease. In this way we are aiming to improve kidney and general health of adults and children. Renowned for its studies in acute and chronic kidney disease and kidney cancers, the CKDR has particular expertise in translating results from laboratory and clinical sciences for application to improve public health outcomes.
The CKDR is one of Australia's leading kidney disease research centres with an international reputation for excellence in research. The researchers of the CKDR are working at the forefront of global trends in research to trial new clinical treatments and to understand the cellular and molecular basis of kidney disease. In this way we are aiming to improve kidney and general health of adults and children. Renowned for its studies in acute and chronic kidney disease and kidney cancers, the CKDR has particular expertise in translating results from laboratory and clinical sciences for application to improve public health outcomes.